Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Krystal Biotech Inc
Swot
Krystal Biotech Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Krystal Biotech Inc has 20 Strengths, 8 Weaknesses, 1 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(20)
Weakness
(8)
Opportunity
(1)
Threats
(3)
Others
(3)
Companies with 10% increase in share price over three months, with rising net profit growth
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Stocks in uptrend most likely to cross above SMA-200 soon
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
PE higher than Industry PE
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Top Losers
Declining Net Cash Flow : Companies not able to generate net cash
Top Losers
Companies with Upcoming Results
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
High Piotroski Score - Companies with strong financials
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
